Inventor · disambiguated record
Anuschirwan Peyman
Also filed as: PEYMAN ANUSCHIRWAN
43 granted patents·6 pending applications·1,153 citations·filing 1991–2005
98Inventor score
Files withHOECHST AG25AVENTIS PHARMA GMBH13SANOFI AVENTIS DEUTSCHLAND3AVENTIS PHARMA S A DEUTSCHLAND1GENENTECH INC1
Top patents by PatentIndex Score
49 records- 0198US7229974B2G cap-stabilized oligonucleotidesSANOFI AVENTIS DEUTSCHLAND·Filed 2001·Granted Jun 12, 2007·116 cites·32 claims
- 0298US7067665B2Oxybenzamide derivatives useful for inhibiting factor Xa or VllaSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Jun 27, 2006·75 cites·16 claims
- 0397US6013639AG cap-stabilized oligonucleotidesHOECHST AG·Filed 1996·Granted Jan 11, 2000·165 cites·46 claims
- 0495US6953857B2Oxybenzamide derivatives useful for inhibiting factor Xa or viiaAVENTIS PHARMA GMBH·Filed 2001·Granted Oct 11, 2005·69 cites·14 claims
- 0592US6348312B1Stabilized oligonucleotides and their useHOECHST AG·Filed 1994·Granted Feb 19, 2002·109 cites·67 claims
- 0692US6313119B1Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesionAVENTIS PHARMA GMBH·Filed 2000·Granted Nov 6, 2001·32 cites·22 claims
- 0791US6340679B1Guanidine derivatives as inhibitors of cell adhesionAVENTIS PHARMA GMBH·Filed 2000·Granted Jan 22, 2002·48 cites·10 claims
- 0889US5874553APhosphonomonoester nucleic acids, process for their preparation, and their useHOECHST AG·Filed 1996·Granted Feb 23, 1999·89 cites·30 claims
- 0986US6723727B1Substituted purine derivatives, processes for their preparation, their use, and compositions comprising themHOECHST AG·Filed 2000·Granted Apr 20, 2004·26 cites·6 claims
- 1086US6121434AG cap-stabilized oligonucleotidesAVENTIS PHARMA GMBH·Filed 1999·Granted Sep 19, 2000·53 cites·14 claims
- 1180US6747016B1Substituted purine derivatives as inhibitors of cell adhesionAVENTIS PHARMA GMBH·Filed 2000·Granted Jun 8, 2004·14 cites·8 claims
- 1280US5563050AAntisense oligonucleotides against HSV 1, and their preparationHOECHST AG·Filed 1994·Granted Oct 8, 1996·59 cites·6 claims
- 1379US6992187B2Process for the preparation of birthonectin receptor antagonistsAVENTIS PHARMA GMBH·Filed 2001·Granted Jan 31, 2006·10 cites·15 claims
- 1479US6033909AOligonucleotide analogs, their preparation and useHOECHST AG·Filed 1994·Granted Mar 7, 2000·32 cites·12 claims
- 1578US6482821B2Vitronectin receptor antagonists, their preparation and their useHOECHST AG·Filed 2001·Granted Nov 19, 2002·8 cites·9 claims
- 1672US6387895B1Vitronectin receptor antagonists, their preparation and their useHOECHST AG·Filed 2001·Granted May 14, 2002·4 cites·10 claims
- 1771US6747148B2Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesionHOECHST MARION ROUSSEL DE GMBH·Filed 2001·Granted Jun 8, 2004·4 cites·6 claims
- 1869US6326487B13 modified oligonucleotide derivativesAVENTIS PHARMA GMBH·Filed 1997·Granted Dec 4, 2001·42 cites·75 claims
- 1969US6127346APhosphonomonoester nucleic acids process for their preparation and their useHOECHST AG·Filed 1998·Granted Oct 3, 2000·26 cites·6 claims
- 2067US5696248A3'-modified oligonucleotide derivativesHOECHST AG·Filed 1995·Granted Dec 9, 1997·37 cites·21 claims
- 2165US6867208B2Vitronectin receptor antagonists, their preparation and their useHOECHST AG·Filed 2002·Granted Mar 15, 2005·1 cites·13 claims
- 2264US6011045AVitronectin receptor antagonists, their preparation and their useHOECHST AG·Filed 1997·Granted Jan 4, 2000·15 cites·10 claims
- 2363US6218387B1Vitronectin receptor anatagonists, their preparation and their useHOECHST AG·Filed 1999·Granted Apr 17, 2001·10 cites·12 claims
- 2463US5990145AVitronectin receptor antagonists, their preparation and their useHOECHST AG·Filed 1997·Granted Nov 23, 1999·21 cites·10 claims
- 2561US7435747B2Guanidine and amidine derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Oct 14, 2008·1 cites·5 claims
- 2659US6492356B1Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonistsAVENTIS PHARMA GMBH·Filed 1998·Granted Dec 10, 2002·17 cites·20 claims
- 2758US6723706B2Modified antisense nucleotides complementary to a section of the human Ha-ras geneAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 20, 2004·12 cites·30 claims
- 2857US2005020523A1Modified antisense nucleotides complementary to a section of the human haras geneAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 2953US5646261A3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and useHOECHST AG·Filed 1993·Granted Jul 8, 1997·10 cites·9 claims
- 3051US5707979APhosphinic acid derivatives, their preparation and their useHOECHST AG·Filed 1995·Granted Jan 13, 1998·12 cites·8 claims
- 3150US5278152A2-formylbenzylphosphonic acid derivatives useful for the treatment of diseases caused by virusesHOECHST AG·Filed 1993·Granted Jan 11, 1994·5 cites·8 claims
- 3249US5804559AProdrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their useHOECHST AG·Filed 1994·Granted Sep 8, 1998·10 cites·6 claims
- 3349US5756749AProcess for the preparation of 1-hydroxy-2-pyridonesHOECHST AG·Filed 1995·Granted May 26, 1998·3 cites·5 claims
- 3447US2003119785A1Vitronectin receptor antagonists, their preparation and useHOECHST AG AND GENENTECH INC·Filed 2002·Application pending·0 cites
- 3546US2005148017A1Antisense oligonucleotides against tenascin for the treating of vitiligoAVENTIS PHARMA GMBH·Filed 2005·Application pending·0 cites
- 3645US2002173656A1Guanidine and amidine derivatives as factor Xa inhibitorsFiled 2001·Application pending·0 cites
- 3744US6878547B1Antisense oligonucleotides against tenascin for treating vitiligoAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 12, 2005·5 cites·23 claims
- 3844US6867213B2(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its useAVENTIS PHARMA GMBH·Filed 2001·Granted Mar 15, 2005·0 cites·6 claims
- 3943US5242908AUse of benzylphosphonic acid derivatives for the treatment of diseases caused by virusesHOECHST AG·Filed 1991·Granted Sep 7, 1993·6 cites·4 claims
- 4043US2003176384A1Antisense oligonucleotides for the inhibition of integrin alphav -subunit expressionFiled 2002·Application pending·0 cites
- 4142US6207663B1Vitronectin receptor antagonists, their preparation and useHOECHST ATKIENGESELLSCHAFT·Filed 1999·Granted Mar 27, 2001·3 cites·10 claims
- 4239US7259159B2Guanidino derivatives as inhibitors of cell adhesionGENENTECH INC·Filed 2001·Granted Aug 21, 2007·0 cites·9 claims
- 4333US5817825AProcess for the preparation of 1-hydroxy-2-pyridonesHOECHST AG·Filed 1995·Granted Oct 6, 1998·0 cites·17 claims
- 4433US5608098ABis(aminomethyl)phosphinic acid derivatives and process for the preparation of bis(aminomethyl)phosphinic acid derivativesHOECHST AG·Filed 1994·Granted Mar 4, 1997·2 cites·8 claims
- 4532US6762190B2Thienylalanine derivatives as inhibitors of cell adhesionAVENTIS PHARMA S A DEUTSCHLAND·Filed 2000·Granted Jul 13, 2004·0 cites·7 claims
- 4629US5663139AInhibitors of retroviral proteasesHOECHST AG·Filed 1993·Granted Sep 2, 1997·2 cites·10 claims
- 4729US2001021772A1Short oligonucleotides for the inhibition of vegf expressionFiled 1999·Application pending·0 cites
- 4828US5629431AInhibitors of retroviral proteasesHOECHST AG·Filed 1995·Granted May 13, 1997·0 cites·2 claims
- 4922US5510504AProcess for the preparation of derivatives of bis(amino-methyl) phosphinic acidHOECHST AG·Filed 1993·Granted Apr 23, 1996·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →